In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Milestone Pharmaceuticals (MIST – Research ...

For the third quarter of 2024, Ascendis Pharma reported a net loss of €99.2 million, or €1.72 per share (basic and diluted) ...

Discover how to navigate CMC processes effectively in drug development. Learn from industry leaders and ensure your project’s ...

Some sectors, including financial and pharmaceutical industries in particular ... arguing that monopolies will stifle the ...

Analyst Gil Blum from Needham maintained a Buy rating on Recursion Pharmaceuticals (RXRX – Research Report) and keeping the price target ...

The software provider Medatixx GmbH & Co. KG wants to collect treatment data from doctors' surgeries and make it available ...

Reorganizing its generics business strategy to target 60% instead of 80% of drugs coming off patent and reallocating resources to complex generics will help Teva offset base business erosion and ...

InProcess-LSP are a young organization, founded in 2014, they have since emerged as providers of groundbreaking process analytical technology for nanoparticle characterization. This article provides a ...

By thoroughly analyzing CMC processes, Mitul Tilala ensures each step is carefully evaluated to identify any areas of concern ...

This journal utilises an Online Peer Review Service (OPRS) for submissions. By clicking "Continue" you will be taken to our partner site https://www.editorialmanager ...

Logos Faith Development wants to build a 62-unit affordable housing complex on land owned by a church in South Los Angeles. The Westchester-based developer of church properties led by the Rev ...